c-MET Antikörper (pTyr1356)
Kurzübersicht für c-MET Antikörper (pTyr1356) (ABIN3028834)
Target
Alle c-MET (MET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pTyr1356
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- This phospho-MET antibody was produced from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding pY1356 of human MET.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the phospho-MET antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Dot blot: 1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the phospho-MET antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- c-MET (MET) (Met Proto-Oncogene (MET))
-
Andere Bezeichnung
- MET
-
Hintergrund
- The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma.
-
UniProt
- P08581
-
Pathways
- RTK Signalweg, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
Target
-